Argenx
ARGX
#1119
Rank
$16.26 B
Marketcap
🇳🇱 Netherlands
Country
$316.37
Share price
1.08%
Change (1 day)
27.06%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Market capitalization of Argenx (ARGX)
Market cap: $16.26 Billion
As of September 2021 Argenx has a market cap of $16.26 Billion. This makes Argenx the world's 1119th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Argenx from 2014 to 2021
| Year | Market cap | Change |
|---|---|---|
| 2021 | $17.33 B | 23.61% |
| 2020 | $14.02 B | 103.85% |
| 2019 | $6.87 B | 96.18% |
| 2018 | $3.50 B | 74.88% |
| 2017 | $2.00 B | |
| 2014 | $0.14 B |